journal
MENU ▼
Read by QxMD icon Read
search

Cardiac Failure Review

journal
https://www.readbyqxmd.com/read/29892479/a-review-of-plant-based-diets-to-prevent-and-treat-heart-failure
#1
REVIEW
Conor P Kerley
Evidence supporting the role of nutrition in heart failure (HF) incidence and severity is growing. A comprehensive search of online databases was conducted using relevant keywords to identify human studies including diet and HF. Several plant-based diets have consistently been associated with decreased HF incidence and severity, notably the Dietary Approaches to Stop Hypertension (DASH) and Mediterranean diets. Several other plant-based dietary patterns, including low-fat diets and the rice diet, also show promise...
May 2018: Cardiac failure review
https://www.readbyqxmd.com/read/29892478/identification-and-treatment-of-central-sleep-apnoea-beyond-serve-hf
#2
REVIEW
William T Abraham, Adam Pleister, Robin Germany
Central sleep apnoea (CSA) occurs in a large proportion of HF patients. CSA has clear detrimental effects, resulting in intermittent hypoxia and sympathetic activation, and is associated with significant morbidity and mortality. Treatment options are limited following the results of a recent trial in which adaptive servo-ventilation resulted in an increase in cardiovascular mortality. Ongoing studies utilising other forms of positive airway pressure may provide additional insight into the results of this trial...
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29892477/bromocriptine-for-the-treatment-of-peripartum-cardiomyopathy
#3
REVIEW
Tobias Koenig, Johann Bauersachs, Denise Hilfiker-Kleiner
Peripartum cardiomyopathy (PPCM) is a life-threatening, pregnancy-associated heart disease that develops towards the end of pregnancy or in the first months following delivery in previously healthy women. Understanding of the pathophysiology has progressed in recent years, highlighting an oxidative-stress mediated cleavage of the nursing hormone prolactin into a toxic 16-kDa prolactin fragment as a major factor driving the disease. The 16-kDa prolactin fragment induces detrimental but potentially reversible effects on heart function...
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29892476/ambulatory-intra-aortic-balloon-pump-in-advanced-heart-failure
#4
REVIEW
Syed Yaseen Naqvi, Ibrahim G Salama, Ayhan Yoruk, Leway Chen
Cardiac transplantation is the gold standard treatment for patients with advanced congestive heart failure that is refractory to maximal medical therapy. However, donor heart availability remains the major limiting factor, resulting in a large number of patients waiting long periods of time before transplantation. As a result, mechanical circulatory support devices have been increasingly used as a 'bridge' in order to sustain organ function and stabilise haemodynamics while patients remain on the transplant waiting list or undergo left ventricular assist device surgery...
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29892475/optimising-heart-failure-therapies-in-the-acute-setting
#5
REVIEW
Mattia Arrigo, Petra Nijst, Alain Rudiger
Acute heart failure (AHF) is a life-threatening condition requiring immediate treatment. The initial therapy should take into account the clinical presentation, pathophysiology at play, precipitating factors and underlying cardiac pathology. Particular attention should be given to polymorbidity and the avoidance of potential iatrogenic harm. Patient preferences and ethical issues should be integrated into the treatment plan at an early stage. The average survival of AHF patients is 2 years and the most vulnerable period is the 3-month time window directly after discharge...
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29892474/ablation-for-atrial-fibrillation-in-heart-failure-with-reduced-ejection-fraction
#6
REVIEW
Jackson J Liang, David J Callans
AF and heart failure with reduced ejection fraction (HFrEF) frequently coexist. Catheter ablation is an increasingly utilised treatment strategy for patients with AF and can be safely performed and is effective in achieving sinus rhythm for patients with HFrEF. Successful ablation may result in improved LV function, clinical heart failure status, quality of life and possibly even mortality. This review summarises the literature analysing efficacy, safety and outcomes of AF ablation for patients with HFrEF.
May 2018: Cardiac failure review
https://www.readbyqxmd.com/read/29892473/iron-therapy-in-heart-failure-ready-for-primetime
#7
REVIEW
Ify R Mordi, Aaron Tee, Chim C Lang
There is an increasing awareness of the prevalence of iron deficiency (ID) in patients with heart failure (HF) and its contributory role in the morbidity and mortality of HF. It is important to note that many HF patients have ID without being anaemic, hence it is vital to screen for ID even in patients with haemoglobin within the normal laboratory range. This review summarises the pathophysiology and epidemiology of ID in HF before discussing the evidence for iron replacement therapy in HF patients. Finally, it discusses the ongoing large outcome trials evaluating iron replacement in HF...
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29892472/pharmacological-interventions-effective-in-improving-exercise-capacity-in-heart-failure
#8
REVIEW
Cristiana Vitale, Spoletini Ilaria, Giuseppe Mc Rosano
Heart failure (HF) is characterised by exercise intolerance, which substantially impairs quality of life (QOL) and prognosis. The aim of this review is to summarise the state of the art on pharmacological interventions that are able to improve exercise capacity in HF. Ivabradine, trimetazidine and intravenous iron are the only drugs included in the European Society of Cardiology HF guidelines that have consistently been shown to positively affect functional capacity in HF. The beneficial effects on HF symptoms, physical performance and QOL using these pharmacological approaches are described...
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29892471/heart-failure-in-sub-saharan-africa
#9
REVIEW
Joseph Gallagher, Kenneth McDonald, Mark Ledwidge, Chris J Watson
Heart failure is a growing problem in sub-Saharan Africa. This arises as the prevalence of risk factors for cardiovascular disease rises, life expectancy increases and causes of heart failure more common in Africa, such as rheumatic heart disease and endomyocardial fibrosis, continue to be a significant issue. Lack of access to diagnostics is an issue with the expense and technical expertise required for echocardiography limiting access. Biomarker strategies may play a role here. Access to essential medicines is also limited and requires a renewed focus by the international community to ensure that appropriate medications are readily available, similar to that which has been implemented for HIV and malaria...
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29892470/left-ventricular-dysfunction-in-the-setting-of-takotsubo-cardiomyopathy-a-review-of-clinical-patterns-and-practical-implications
#10
REVIEW
Kenan Yalta, Mustafa Yilmaztepe, Cafer Zorkun
Takotsubo cardiomyopathy (TTC) is primarily regarded as a form of acute and transient myocardial disease with a variety of characteristic wall-motion abnormalities. Importantly, a significant portion of TTC cases generally present with variable degrees of acute left ventricular (LV) dysfunction with or without clinical HF. On the other hand, LV dysfunction in the setting of TTC has been universally and exclusively considered as a synonym for systolic dysfunction, potentially overlooking other forms of myocardial pathologies, including transient diastolic dysfunction, in this setting...
May 2018: Cardiac failure review
https://www.readbyqxmd.com/read/29892469/heart-failure-with-mid-range-ejection-fraction-and-how-to-treat-it
#11
REVIEW
Yuri Lopatin
The introduction of heart failure (HF) with mid-range ejection fraction (HFmrEF) as a distinct phenotype has achieved its aim of stimulating research into the underlying characteristics, pathophysiology and treatment of HF patients with left ventricular ejection fraction of 40-49 %. Comparison of clinical characteristics, comorbidities, outcomes and prognosis among patients with HF with preserved ejection fraction, HFmrEF and HF with reduced ejection fraction allowed consideration of HFmrEF as an intermediate phenotype, which often resembles HF with reduced ejection fraction more than HF with preserved ejection fraction...
May 2018: Cardiac failure review
https://www.readbyqxmd.com/read/29892468/what-is-heart-failure-with-mid-range-ejection-fraction-a-new-subgroup-of-patients-with-heart-failure
#12
REVIEW
Sunil K Nadar, Osama Tariq
Since the publication of European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) in 2016, a new class of HF has been defined, namely HF with mildly reduced ejection fraction (HFmrEF). Although the name was new, there had long been awareness of the existence of a grey area between the two established classes of HF: HF with reduced ejection fraction and HF with preserved ejection fraction. Patients between these two classes were previously either excluded from HF studies or were included in the other groups...
May 2018: Cardiac failure review
https://www.readbyqxmd.com/read/29844924/erratum-to-impact-of-exercise-training-on-peak-oxygen-uptake-and-its-determinants-in-heart-failure-with-preserved-ejection-fraction
#13
Wesley J Tucker, Michael D Nelson, Rhys I Beaudry, Martin Halle, Satyam Sarma, Dalane W Kitzman, Andre La Gerche, Mark J Haykowsky
[This corrects the article DOI: 10.15420/cfr.2016:16:2.].
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29844923/foreword
#14
EDITORIAL
Andrew Js Coats, Giuseppe Rosano
No abstract text is available yet for this article.
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29387468/the-future-role-of-cardio-oncologists
#15
Radek Pudil
Cardiovascular (CV) disease and cancer remain the two most common causes of mortality in developed countries; however, progress in the treatment of malignant diseases significantly improved survival of oncological patients. Similarly, there is an increased number of the patients with malignancy who have a history of CV disease or an increased CV risk. Rates of CV problems from cancer-related therapeutics are high, and cardiotoxicity is the second most common cause of morbidity and mortality in cancer survivors...
November 2017: Cardiac Failure Review
https://www.readbyqxmd.com/read/29387467/sleep-disordered-breathing-during-congestive-heart-failure-to-intervene-or-not-to-intervene
#16
Ali Valika, Maria Rosa Costanzo
Sleep-disordered breathing is common in heart failure patients and is associated with increased morbidity and mortality. Central sleep apnea occurs more commonly in heart failure-reduced ejection fraction, and obstructive sleep apnea occurs more frequently in heart failure with preserved ejection fraction. Although the two types of sleep-disordered breathing have distinct pathophysiologic mechanisms, both contribute to abnormal cardiovascular consequences. Treatment with continuous positive airway pressure for obstructive sleep apnea in heart failure has been well defined, whereas treatment strategies for central sleep apnea in heart failure continue to evolve...
November 2017: Cardiac failure review
https://www.readbyqxmd.com/read/29387466/quality-of-physician-adherence-to-guideline-recommendations-for-life-saving-treatment-in-heart-failure-an-international-survey
#17
Martin R Cowie, Michel Komajda
QUALIFY (QUality of Adherence to guideline recommendations for LIFe-saving treatment in heart failure surveY) showed that good physician adherence to guideline recommendations for angiotensin converting enzyme inhibitors/angiotensin receptor blockers, beta blockers, mineralocorticoid receptor antagonists and ivabradine, with prescription of at least 50 % of recommended dosages, was associated with better 6-month outcomes than moderate or poor adherence. Poor adherence was associated with higher all-cause mortality (hazard ratio 2...
November 2017: Cardiac failure review
https://www.readbyqxmd.com/read/29387465/predictors-of-post-discharge-mortality-among-patients-hospitalized-for-acute-heart-failure
#18
Ovidiu Chioncel, Sean P Collins, Stephen J Greene, Peter S Pang, Andrew P Ambrosy, Elena-Laura Antohi, Muthiah Vaduganathan, Javed Butler, Mihai Gheorghiade
Acute Heart Failure (AHF) is a " multi-event disease" and hospitalisation is a critical event in the clinical course of HF. Despite relatively rapid relief of symptoms, hospitalisation for AHF is followed by an increased risk of death and re-hospitalisation. In AHF, risk stratification from clinically available data is increasingly important in evaluating long-term prognosis. From the perspective of patients, information on the risk of mortality and re-hospitalisation would be helpful in providing patients with insight into their disease...
November 2017: Cardiac Failure Review
https://www.readbyqxmd.com/read/29387464/value-of-telemonitoring-and-telemedicine-in-heart-failure-management
#19
Gian Franco Gensini, Camilla Alderighi, Raffaele Rasoini, Marco Mazzanti, Giancarlo Casolo
The use of telemonitoring and telemedicine is a relatively new but quickly developing area in medicine. As new digital tools and applications are being created and used to manage medical conditions such as heart failure, many implications require close consideration and further study, including the effectiveness and safety of these telemonitoring tools in diagnosing, treating and managing heart failure compared to traditional face-to-face doctor-patient interaction. When compared to multidisciplinary intervention programs which are frequently hindered by economic, geographic and bureaucratic barriers, non-invasive remote monitoring could be a solution to support and promote the care of patients over time...
November 2017: Cardiac failure review
https://www.readbyqxmd.com/read/29387463/applying-heart-failure-management-to-improve-health-outcomes-but-which-one
#20
Yih-Kai Chan, Alice M David, Caitlyn Mainland, Lei Chen, Simon Stewart
We report on our learning from many years of research testing the value of nurse-led, multidisciplinary, home-based management of heart failure. We discuss and highlight the key challenges we have experienced in testing this model of care relative to alternatives and evolving patient population. Accordingly, we propose a pragmatic approach to adapt current models of care to meet the needs of increasingly complex (and costly) patients with multimorbidity.
November 2017: Cardiac Failure Review
journal
journal
55933
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"